CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-08-06 00:00 |
기타경영사항(특허권취득)(자율공시)(BTK 키나아제 억제제로서의 2,3-디하이드로-이소인돌-1-온 유도체 및 이를 함유하는 약학적 조성물)
|
Korean | 5.3 KB | ||
| 2019-08-05 00:00 |
기타경영사항(특허권취득)(자율공시)(5-(4-(아미노설포닐)페닐)-2,2-디메틸-4-(3-플루오로페닐)-3(2H)-퓨라논을 포함하는 약학적 조…
|
Korean | 5.9 KB | ||
| 2019-05-16 00:00 |
기업설명회(IR)개최
|
Korean | 7.5 KB | ||
| 2019-05-15 00:00 |
분기보고서 (2019.03)
|
Korean | 1.8 MB | ||
| 2019-05-07 00:00 |
신주인수권행사가액의조정(제13회차)
|
Korean | 12.3 KB | ||
| 2019-05-07 00:00 |
전환가액의조정(제12회차)
|
Korean | 12.1 KB | ||
| 2019-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2019-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2019-04-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.9 KB | ||
| 2019-04-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.9 KB | ||
| 2019-04-05 00:00 |
기업설명회(IR)개최
|
Korean | 7.5 KB | ||
| 2019-04-01 00:00 |
사업보고서 (2018.12)
|
Korean | 1.8 MB | ||
| 2019-03-26 00:00 |
기타경영사항(자율공시)(CG-806 미국 임상1상 시험 승인)
|
Korean | 9.6 KB | ||
| 2019-03-22 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.4 KB | ||
| 2019-03-22 00:00 |
정기주주총회결과
|
Korean | 28.3 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
